Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Europe Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Reagents, Software & Services)
5.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
5.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
5.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
5.2.5. By Country
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End User
5.3.5. By Country
5.4. Europe: Country Analysis
5.4.1. France Diagnostics Market Outlook
5.4.1.1. Market Size & Forecast
5.4.1.1.1. By Value
5.4.1.2. Market Share & Forecast
5.4.1.2.1. By Product
5.4.1.2.2. By Technology
5.4.1.2.3. By Application
5.4.1.2.4. By End User
5.4.2. Germany Diagnostics Market Outlook
5.4.2.1. Market Size & Forecast
5.4.2.1.1. By Value
5.4.2.2. Market Share & Forecast
5.4.2.2.1. By Product
5.4.2.2.2. By Technology
5.4.2.2.3. By Application
5.4.2.2.4. By End User
5.4.3. United Kingdom Diagnostics Market Outlook
5.4.3.1. Market Size & Forecast
5.4.3.1.1. By Value
5.4.3.2. Market Share & Forecast
5.4.3.2.1. By Product
5.4.3.2.2. By Technology
5.4.3.2.3. By Application
5.4.3.2.4. By End User
5.4.4. Italy Diagnostics Market Outlook
5.4.4.1. Market Size & Forecast
5.4.4.1.1. By Value
5.4.4.2. Market Share & Forecast
5.4.4.2.1. By Product
5.4.4.2.2. By Technology
5.4.4.2.3. By Application
5.4.4.2.4. By End User
5.4.5. Spain Diagnostics Market Outlook
5.4.5.1. Market Size & Forecast
5.4.5.1.1. By Value
5.4.5.2. Market Share & Forecast
5.4.5.2.1. By Product
5.4.5.2.2. By Technology
5.4.5.2.3. By Application
5.4.5.2.4. By End User
5.4.6. Finland Diagnostics Market Outlook
5.4.6.1. Market Size & Forecast
5.4.6.1.1. By Value
5.4.6.2. Market Share & Forecast
5.4.6.2.1. By Product
5.4.6.2.2. By Technology
5.4.6.2.3. By Application
5.4.6.2.4. By End User
5.4.7. Greece Diagnostics Market Outlook
5.4.7.1. Market Size & Forecast
5.4.7.1.1. By Value
5.4.7.2. Market Share & Forecast
5.4.7.2.1. By Product
5.4.7.2.2. By Technology
5.4.7.2.3. By Application
5.4.7.2.4. By End User
5.4.8. Portugal Diagnostics Market Outlook
5.4.8.1. Market Size & Forecast
5.4.8.1.1. By Value
5.4.8.2. Market Share & Forecast
5.4.8.2.1. By Product
5.4.8.2.2. By Technology
5.4.8.2.3. By Application
5.4.8.2.4. By End User
5.4.9. Bulgaria Diagnostics Market Outlook
5.4.9.1. Market Size & Forecast
5.4.9.1.1. By Value
5.4.9.2. Market Share & Forecast
5.4.9.2.1. By Product
5.4.9.2.2. By Technology
5.4.9.2.3. By Application
5.4.9.2.4. By End User
5.4.10. Croatia Diagnostics Market Outlook
5.4.10.1. Market Size & Forecast
5.4.10.1.1. By Value
5.4.10.2. Market Share & Forecast
5.4.10.2.1. By Product
5.4.10.2.2. By Technology
5.4.10.2.3. By Application
5.4.10.2.4. By End User
6. Market Dynamics
6.1. Drivers
6.2. Challenges
7. Market Trends & Developments
8. Competitive Landscape
8.1. Business Overview
8.2. Product Offerings
8.3. Recent Developments
8.4. Financials (As Reported)
8.5. Key Personnel
8.6. SWOT Analysis
8.6.1. Roche Diagnostics GmbH
8.6.2. Ortho Clinical Diagnostics
8.6.3. Abbott Laboratories, Inc.
8.6.4. Hologic, Inc. (Gen-Probe)
8.6.5. Qiagen N.V.
8.6.6. Bio-Rad Laboratories, Inc.
8.6.7. Quidel Corporation
8.6.8. Becton, Dickinson (BD) Company, Inc.
8.6.9. bioMerieux, Inc.
8.6.10. Siemens Healthcare GmbH
9. Strategic Recommendations